UAL
56
-4
MCHP
59
7
GIS
60
-3
AVB
67
3
UPS
46
-2
HUM
42
-6
CSX
40
-3
EMN
72
-3
ZION
55
2
PEP
63
6
MRO
44
-3
GPC
61
-3
MKC
47
3
WMT
64
5
JPM
64
2
MTCH
48
2
JCI
47
-2
EW
42
2
PEG
48
2
FSLR
58
-3
UAL
56
-4
MCHP
59
7
GIS
60
-3
AVB
67
3
UPS
46
-2
HUM
42
-6
CSX
40
-3
EMN
72
-3
ZION
55
2
PEP
63
6
MRO
44
-3
GPC
61
-3
MKC
47
3
WMT
64
5
JPM
64
2
MTCH
48
2
JCI
47
-2
EW
42
2
PEG
48
2
FSLR
58
-3
Financhill
Back

Universe Pharmaceuticals 10K Form

Buy
62

UPC
Universe Pharmaceuticals

Last Price:
1.92
Seasonality Move:
-34.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UPC News And Ratings

See the #1 stock for the next 7 days that we like better than UPC

UPC Financial Statistics

Sales & Book Value

Annual Sales: $32.31M
Cash Flow: $0
Price / Cash Flow: 7.22
Annual Sales: $10.84
Price / Book: 0.2

Profitability

EPS (TTM): -1.70000
Net Income (TTM): $-6.16M
Gross Margin: $10.32M
Return on Equity: -13.89%
Return on Assets: -10.09%

Universe Pharmaceuticals Earnings Forecast

Key Universe Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for UPC is 31.93%.
  • The Selling, General & Administrative Expenses for UPC have been equal to 27.86% of Gross Profit Margin.
  • The Research & Development expenses have been 15.04% of Revenue.
  • The Interest Expense is -2.54% of Operating Income.
  • The Net Earning history of UPC is -19.08% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Universe Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: UPC
Website: universe-pharmacy.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 2.68
Quick Ratio: 2.13

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

UPC Technical Analysis vs Fundamental Analysis

Buy
62
Universe Pharmaceuticals (UPC) is a Buy

Is Universe Pharmaceuticals a Buy or a Sell?